Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Blood|October 9, 2009
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemiaDalemari Crowther-Swanepoel, Mobshra Qureshi, Martin J S Dyer, et al.
British Journal of Sports Medicine|December 3, 2015
Professional Rugby Union players have a 60% greater risk of time loss injury after concussion: a 2-season prospective study of clinical outcomesMatthew Cross, Simon Kemp, Andrew Smith, et al.
Case Reports in Oncology|February 6, 2023
Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumour with an NF1 Mutation Responding to Trametinib: A Case ReportNadia Hitchen, Matthew Cross, George Laking, et al.
Australian and New Zealand Journal of Public Health|January 19, 2010
Fluoride content of powdered infant formula meets Australian Food Safety StandardsHelen Clifford, Henry Olszowy, Megan Young, et al.
Marine Environmental Research|May 3, 2011
Comparison of methods used for computing the impact of sound on the marine environmentScott Schecklman, Dorian Houser, Matthew Cross, et al.
Cancer|September 22, 2007
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemiaMonica Else, Nnenna Osuji, Francesco Forconi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Chronic lymphocytic leukemia: new concepts for future therapyWilliam G Wierda, Nicholas Chiorazzi, Claire Dearden, et al.
Hemasphere|October 16, 2020
Controversies in the Treatment of Peripheral T-cell LymphomaEmmanuel Bachy, Alessandro Broccoli, Claire Dearden, et al.
Cancer|October 26, 2005
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 yearsMonica Else, Rosa Ruchlemer, Nnenna Osuji, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2017
Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20' ethyl substituentOliver Allemann, R Matthew Cross, Manuela M Brütsch, et al.
Pageof 11